Pdt Partners, LLC Innoviva, Inc. Transaction History

Pdt Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $212,474 - $278,541	18,301 New	18,301 $212,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $253,449 - $351,856	-17,699 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $281,591 - $331,325	17,699 New	17,699 $305,000
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $213,666 - $285,804	-22,901 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $236,567 - $331,835	22,901 New	22,901 $239,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $153,966 - $204,484	-13,400 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $108,673 - $204,082	13,400 New	13,400 $158,000
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $4.17 Million - $4.8 Million	-305,599 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $521,794 - $682,914	-38,824 Reduced 11.27%	305,599 $4.22 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $2,056 - $2,531	149 Added 0.04%	344,423 $5.74 Million
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $989,143 - $1.24 Million	-84,326 Reduced 19.67%	344,274 $4.89 Million
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $5.17 Million - $6.05 Million	428,600	428,600 $6.05 Million

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.